title: The Epstein-Barr virus (EBV) glycoprotein B cytoplasmic C-terminal tail domain regulates the energy requirement for EBV-induced membrane fusion.
abstract: The entry of enveloped viruses into host cells is preceded by membrane fusion, which in Epstein-Barr virus (EBV) is thought to be mediated by the refolding of glycoprotein B (gB) from a prefusion to a postfusion state. In our current studies, we characterized a gB C-terminal tail domain (CTD) mutant truncated at amino acid 843 (gB843). This truncation mutant is hyperfusogenic as monitored by syncytium formation and in a quantitative fusion assay and is dependent on gH/gL for fusion activity. gB843 can rescue the fusion function of other glycoprotein mutants that have null or decreased fusion activity in epithelial and B cells. In addition, gB843 requires less gp42 and gH/gL for fusion, and can function in fusion at a lower temperature than wild-type gB, indicating a lower energy requirement for fusion activation. Since a key step in fusion is the conversion of gB from a prefusion to an active postfusion state by gH/gL, gB843 may access this activated gB state more readily. Our studies indicate that the gB CTD may participate in the fusion function by maintaining gB in an inactive prefusion form prior to activation by receptor binding. Importance: Diseases resulting from Epstein-Barr virus (EBV) infection in humans range from the fairly benign disease infectious mononucleosis to life-threatening cancer. As an enveloped virus, EBV must fuse with a host cell membrane for entry and infection by using glycoproteins gH/gL, gB, and gp42. Among these glycoproteins, gB is thought to be the protein that executes fusion. To further characterize the function of the EBV gB cytoplasmic C-terminal tail domain (CTD) in fusion, we used a previously constructed CTD truncation mutant and studied its fusion activity in the context of other EBV glycoprotein mutants. From these studies, we find that the gB CTD regulates fusion by altering the energy requirements for the triggering of fusion mediated by gH/gL or gp42. Overall, our studies may lead to a better understanding of EBV fusion and entry, which may result in novel therapies that target the EBV entry step.
authors.affiliation: Department of Microbiology and Immunology, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
authors.forename: Jia
authors.initials: J
authors.lastname: Chen
authors.affiliation: Department of Pharmacology, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA.
authors.forename: Xianming
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Department of Structural Biology, Stanford University School of Medicine, Stanford, California, USA.
authors.forename: Theodore S
authors.initials: TS
authors.lastname: Jardetzky
authors.affiliation: Department of Microbiology and Immunology, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA r-longnecker@northwestern.edu.
authors.forename: Richard
authors.initials: R
authors.lastname: Longnecker
mesh_terms: D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D004854:Herpesvirus 4, Human / Q000502:physiology*; D008561:Membrane Fusion / Q000502:physiology*; D009154:Mutation; D013696:Temperature; D014764:Viral Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*
chemical_list: C060207:Epstein-Barr virus glycoprotein gp110; D014764:Viral Proteins
references.citation: Virology. 2001 Nov 10;290(1):106-14
references.pmid: 11882994
references.citation: J Virol. 2006 Oct;80(19):9444-54
references.pmid: 16973550
references.citation: Virology. 1995 Jul 10;210(2):264-72
references.pmid: 7618266
references.citation: J Virol. 1997 Feb;71(2):1667-70
references.pmid: 8995697
references.citation: mBio. 2012 Jan 03;3(1):
references.pmid: 22215569
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2880-5
references.pmid: 19196955
references.citation: J Virol. 2007 May;81(9):4520-32
references.pmid: 17301148
references.citation: J Virol. 2013 Feb;87(3):1430-42
references.pmid: 23152509
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17474-9
references.pmid: 15583133
references.citation: J Virol. 2012 Mar;86(5):2600-9
references.pmid: 22171273
references.citation: mBio. 2013 Feb 26;4(2):
references.pmid: 23443004
references.citation: Virus Genes. 2010 Jun;40(3):307-19
references.pmid: 20162447
references.citation: Virology. 2008 Sep 30;379(2):181-90
references.pmid: 18687450
references.citation: Science. 2006 Jul 14;313(5784):187-91
references.pmid: 16840692
references.citation: Virology. 2007 Jun 20;363(1):148-55
references.pmid: 17307213
references.citation: J Virol. 2004 Jun;78(11):5946-56
references.pmid: 15140992
references.citation: J Virol. 2010 May;84(10):4923-35
references.pmid: 20200237
references.citation: mBio. 2013 Jan 22;4(1):e00571-12
references.pmid: 23341550
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10559-64
references.pmid: 18653756
references.citation: Structure. 2009 Feb 13;17(2):223-33
references.pmid: 19217393
references.citation: Virology. 2000 Apr 25;270(1):17-30
references.pmid: 10772976
references.citation: J Virol. 2005 Sep;79(17):10923-30
references.pmid: 16103144
references.citation: J Virol. 1998 Jul;72(7):5552-8
references.pmid: 9621012
references.citation: J Virol. 1997 Jun;71(6):4657-62
references.pmid: 9151859
references.citation: Nat Struct Mol Biol. 2008 Oct;15(10):1024-30
references.pmid: 18776902
references.citation: J Virol. 1993 Apr;67(4):2191-201
references.pmid: 8383236
references.citation: J Virol. 2012 Aug;86(15):8171-84
references.pmid: 22623783
references.citation: J Virol. 2013 Sep;87(18):10083-93
references.pmid: 23843643
references.citation: J Virol. 1998 Jan;72(1):158-63
references.pmid: 9420211
references.citation: J Virol. 2013 Apr;87(7):3620-7
references.pmid: 23325693
references.citation: J Virol. 2009 Jul;83(13):6664-72
references.pmid: 19369343
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9217-22
references.pmid: 15197264
references.citation: Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20464-9
references.pmid: 19920174
references.citation: J Virol. 1986 Nov;60(2):803-6
references.pmid: 3022014
references.citation: Nat Rev Microbiol. 2011 May;9(5):369-81
references.pmid: 21478902
references.citation: Cell Mol Life Sci. 2008 Jun;65(11):1716-28
references.pmid: 18345480
references.citation: J Virol. 1993 Apr;67(4):2396-401
references.pmid: 8383250
references.citation: Virology. 2011 Apr 25;413(1):26-38
references.pmid: 21376360
references.citation: J Virol. 2009 Jan;83(2):734-47
references.pmid: 18987135
references.citation: Virology. 2007 Aug 15;365(1):157-65
references.pmid: 17477951
references.citation: J Virol. 1985 Dec;56(3):807-13
references.pmid: 2999435
references.citation: Nat Med. 2002 Jun;8(6):594-9
references.pmid: 12042810
references.citation: J Virol. 2007 Sep;81(17):9216-29
references.pmid: 17581996
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9288-93
references.pmid: 15964978
references.citation: Mol Cell. 2002 Feb;9(2):375-85
references.pmid: 11864610
references.citation: Science. 2006 Jul 14;313(5784):217-20
references.pmid: 16840698
references.citation: J Virol. 2013 Sep;87(18):10139-47
references.pmid: 23843635
references.citation: Virology. 2013 Feb 5;436(1):118-26
references.pmid: 23200314
references.citation: J Virol. 1995 Jul;69(7):3987-94
references.pmid: 7539502
references.citation: J Virol. 2010 Feb;84(4):2001-12
references.pmid: 19939928
references.citation: J Virol. 2005 Oct;79(19):12408-15
references.pmid: 16160168